Trial intelligence / Profile preview

Feasibility, efficacy and acceptability of injected buprenorphine for heroin users not responding to maintenance treatment

2011-001088-28Phase 4Terminated

Sponsor
South London and Maudsley NHS Foundation Trust
Start
Dec 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of buprenorphine in heroin addiction, opioid use disorder (OUD), sponsored by South London and Maudsley NHS Foundation Trust. Started Dec 2015; status: terminated.

02

Drugs

buprenorphine
03

Conditions

heroin addictionopioid use disorder (OUD)

Beyond the preview

Go deeper on 2011-001088-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001088-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call